• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗高尿酸血症治疗对痛风临床及影像学进展的影响。

Influence of antihyperuricemic therapy on the clinical and radiographic progression of gout.

作者信息

McCarthy G M, Barthelemy C R, Veum J A, Wortmann R L

机构信息

Department of Medicine, Medical College of Wisconsin, Milwaukee 53226.

出版信息

Arthritis Rheum. 1991 Dec;34(12):1489-94. doi: 10.1002/art.1780341203.

DOI:10.1002/art.1780341203
PMID:1747133
Abstract

Ten years ago, we studied the clinical and radiographic manifestations of gout in 60 patients and described 3 patterns of disease. To determine the consequences of management over a 10-year period, we recently reassessed the 39 available patients of this population. We found that although reduced tophaceous deposition on physical examination correlated with normalization of the serum urate concentration, no correlation existed between radiographic changes and mean serum urate concentrations. Progression of gouty changes on radiography reflected progressive deformity on physical examination. We have described the radiographic changes that occurred in a well-characterized population of subjects with gout over 10 years and determined that serum urate concentrations alone may not provide an effective means of monitoring the progression of tophaceous disease in bone.

摘要

十年前,我们研究了60例痛风患者的临床和影像学表现,并描述了3种疾病模式。为了确定10年期间治疗的效果,我们最近重新评估了该人群中39例可联系到的患者。我们发现,虽然体格检查中痛风石沉积的减少与血清尿酸盐浓度的正常化相关,但影像学改变与平均血清尿酸盐浓度之间不存在相关性。X线片上痛风改变的进展反映了体格检查中渐进性畸形。我们描述了在一组特征明确的痛风患者人群中10年间发生的影像学改变,并确定仅血清尿酸盐浓度可能无法提供监测骨骼中痛风石疾病进展的有效方法。

相似文献

1
Influence of antihyperuricemic therapy on the clinical and radiographic progression of gout.抗高尿酸血症治疗对痛风临床及影像学进展的影响。
Arthritis Rheum. 1991 Dec;34(12):1489-94. doi: 10.1002/art.1780341203.
2
Reduce serum uric acid levels before withdrawing antihyperuricemic therapy in patients with tophaceous gout.在痛风石性痛风患者停用降尿酸治疗前降低血清尿酸水平。
Arthritis Rheum. 1992 Oct;35(10):1252. doi: 10.1002/art.1780351024.
3
Serum urate during bouts of acute gouty arthritis.急性痛风性关节炎发作期间的血清尿酸盐
J Rheumatol. 1997 Nov;24(11):2265-6.
4
Improving the use of allopurinol in chronic gout: monitoring oxypurinol levels to guide therapy.提高慢性痛风中别嘌醇的使用:监测氧嘌呤醇水平以指导治疗。
Clin Pharmacol Ther. 2011 Sep;90(3):363-4. doi: 10.1038/clpt.2011.146.
5
Using serum urate levels to determine the period free of gouty symptoms after withdrawal of long-term urate-lowering therapy: a prospective study.利用血清尿酸水平确定长期降尿酸治疗停药后痛风症状缓解期:一项前瞻性研究。
Arthritis Rheum. 2006 Oct 15;55(5):786-90. doi: 10.1002/art.22232.
6
Relationship between serum urate and plasma oxypurinol in the management of gout: determination of minimum plasma oxypurinol concentration to achieve a target serum urate level.在痛风管理中血清尿酸与血浆别嘌呤醇的关系:确定达到目标血清尿酸水平的最低血浆别嘌呤醇浓度。
Clin Pharmacol Ther. 2011 Sep;90(3):392-8. doi: 10.1038/clpt.2011.113. Epub 2011 Jul 27.
7
Presence of monosodium urate crystal deposition by dual-energy CT in patients with gout treated with allopurinol.在别嘌醇治疗的痛风患者中,双能 CT 存在单钠尿酸盐晶体沉积。
Ann Rheum Dis. 2018 Mar;77(3):364-370. doi: 10.1136/annrheumdis-2017-212046. Epub 2017 Nov 16.
8
Effect of low dose daily aspirin on serum urate levels and urinary excretion in patients receiving probenecid for gouty arthritis.小剂量每日服用阿司匹林对接受丙磺舒治疗痛风性关节炎患者血清尿酸水平及尿排泄的影响。
J Rheumatol. 2000 Dec;27(12):2873-6.
9
Fenofibrate enhances urate reduction in men treated with allopurinol for hyperuricaemia and gout.非诺贝特可增强接受别嘌醇治疗的高尿酸血症和痛风男性患者的尿酸降低效果。
Rheumatology (Oxford). 2003 Feb;42(2):321-5. doi: 10.1093/rheumatology/keg103.
10
New urate depositions on dual-energy computed tomography in gouty arthritis during urate-lowering therapy.尿酸盐降低治疗期间痛风性关节炎患者双能计算机断层扫描上的新尿酸盐沉积。
Rheumatol Int. 2017 Aug;37(8):1365-1372. doi: 10.1007/s00296-017-3724-3. Epub 2017 Apr 26.

引用本文的文献

1
Physical Impairments in People With Gout: A Scoping Review.痛风患者的身体损伤:一项范围综述
Musculoskeletal Care. 2025 Jun;23(2):e70103. doi: 10.1002/msc.70103.
2
Tophus resolution in patients with chronic refractory gout who have persistent urate-lowering responses to pegloticase.接受培戈洛酶治疗后持续降低尿酸且难治性慢性痛风患者的痛风石溶解。
Arthritis Res Ther. 2018 Dec 29;20(1):286. doi: 10.1186/s13075-018-1782-x.
3
An MRI assessment of chronic synovial-based inflammation in gout and its correlation with serum urate levels.
痛风中基于慢性滑膜炎症的MRI评估及其与血清尿酸水平的相关性。
Clin Rheumatol. 2015 Feb;34(2):345-51. doi: 10.1007/s10067-014-2644-9. Epub 2014 May 7.
4
Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiative.多国循证推荐意见:痛风的诊断与管理——3e 倡议中广泛的风湿病学家专家组对系统文献回顾和专家意见的整合。
Ann Rheum Dis. 2014 Feb;73(2):328-35. doi: 10.1136/annrheumdis-2013-203325. Epub 2013 Jul 18.
5
Imaging in gout--what can we learn from MRI, CT, DECT and US?痛风的影像学表现——MRI、CT、双能 CT 和 US 能提供哪些信息?
Arthritis Res Ther. 2011;13(6):246. doi: 10.1186/ar3489. Epub 2011 Nov 4.
6
Imaging of gout: findings and utility.痛风的影像学表现:特征与应用价值。
Arthritis Res Ther. 2009;11(3):232. doi: 10.1186/ar2687. Epub 2009 Jun 17.
7
Management of gout in older adults: barriers to optimal control.老年人痛风的管理:实现最佳控制的障碍
Drugs Aging. 2007;24(1):21-36. doi: 10.2165/00002512-200724010-00002.
8
The advanced imaging of gouty tophi.痛风石的高级成像
Curr Rheumatol Rep. 2006 Jun;8(3):231-5. doi: 10.1007/s11926-996-0030-6.
9
EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).欧洲抗风湿病联盟关于痛风的循证推荐意见。第二部分:管理。欧洲抗风湿病联盟国际临床研究包括治疗学常务委员会(ESCISIT)特别工作组报告
Ann Rheum Dis. 2006 Oct;65(10):1312-24. doi: 10.1136/ard.2006.055269. Epub 2006 May 17.
10
Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol.黄嘌呤氧化酶抑制剂的治疗作用:自别嘌醇发现半个世纪后的复兴
Pharmacol Rev. 2006 Mar;58(1):87-114. doi: 10.1124/pr.58.1.6.